Skip to main content
. 2014 May 9;6(2):1111–1127. doi: 10.3390/cancers6021111

Figure 3.

Figure 3

KYC reduces tumor multiplicity in an inflammation-promoted model of lung carcinogenesis. (A) BHT induced a 5-fold increase in lung tumor multiplicity (MCA: 1.0 ± 0.4; MCA/BHT: 5.3 ± 1.0). Lung tumor multiplicity was reduced by 50% in mice treated with KYC (3.1 ± 1.4); (B) Tumor size (i.e., diameter) was unchanged between treatment groups.